HRT Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

HRT Financial’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26,697	Closed	-$1.96M	–	3694
2025 Q3	$1.96M	Buy	+26,697	New	+$1.7M	0.01%	1163
2025 Q1	–	Sell	-9,158	Closed	-$378K	–	3049
2024 Q4	$378K	Buy	+9,158	New	+$382K	﹤0.01%	1588
2023 Q4	–	Sell	-29,097	Closed	-$919K	–	2783
2023 Q3	$919K	Buy	+29,097	New	+$797K	0.01%	1027
2022 Q2	–	Sell	-10,774	Closed	-$237K	–	3394
2022 Q1	$237K	Buy	+10,774	New	+$220K	﹤0.01%	2395
2021 Q4	–	Sell	-10,792	Closed	-$214K	–	3722
2021 Q3	$214K	Sell	10,792 -13,214	-55%	-$215K	﹤0.01%	2644
2021 Q2	$415K	Buy	+24,006	New	+$430K	﹤0.01%	1931
2021 Q1	–	Sell	-15,024	Closed	-$262K	–	2972
2020 Q4	$262K	Buy	+15,024	New	+$295K	0.01%	1369

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRT Financial's MIRM Position: Q4 2025 in Review

HRT Financial sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 26,697 shares — an estimated $1.96M sold.

HRT Financial first reported a position in MIRM in Q4 2020 and held it in 7 quarters. The position peaked at $1.96M in Q3 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

HRT Financial reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 26,697 Mirum Pharmaceuticals shares in Q4 2025, an estimated $1.96M.
HRT Financial first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 7 quarters.
HRT Financial's Mirum Pharmaceuticals position peaked at $1.96M in Q3 2025.
281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.